Drug intelligence / Profile preview

Swisse Nutra+ Cholesterol Balance

Development stage: Unknown
Lead developer: Swisse
Modality: Small Molecules
Administration: Oral

Overview

Swisse Nutra+ Cholesterol Balance is a nutraceutical supplement developed by Swisse Wellness for the management of hypercholesterolemia. It was evaluated in a randomized, double-blind, placebo-controlled clinical trial (NCT04783714) involving Australian adults with fasting LDL-cholesterol levels between 2.5 mmol/L and 5 mmol/L. The study assessed the efficacy of a daily regimen of three capsules over a four-month period in reducing serum LDL-cholesterol levels in otherwise healthy individuals without a history of cardiovascular disease. As a nutraceutical, it is formulated to provide physiological benefits in lipid management through natural active ingredients.

Brand names: Swisse Nutra+ Cholesterol Balance

Beyond the preview

Go deeper on Swisse Nutra+ Cholesterol Balance.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Swisse Nutra+ Cholesterol Balance.

Explore the full profile